<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39465214</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2732-494X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</Title><ISOAbbreviation>Antimicrob Steward Healthc Epidemiol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 seropositivity among healthcare professionals in a rural state.</ArticleTitle><Pagination><StartPage>e190</StartPage><MedlinePgn>e190</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e190</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/ash.2024.420</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">We evaluated SARS-CoV-2 anti-nucleocapsid (anti-N) seroconversion and seroreversion rates, risk factors associated with SARS-CoV-2 seroconversion, and COVID-19 risk perceptions among academic healthcare center employees in a rural state.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Among employees aged ≥18 years who completed a screening survey (n = 1,377), we invited all respondents reporting previous COVID-19 (n = 85; 82 accepted) and a random selection of respondents not reporting previous COVID-19 (n = 370; 220 accepted) to participate. Participants completed surveys and provided blood samples at 3-month intervals (T0, T3, T6, T9). We used logistic regression to identify risk factors for seropositivity at T0.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The cohort was primarily direct patient caregivers (205/302; 67.9%), white (278/302; 92.1%), and female (212/302; 70.2%). At T0, 86/302 (28.4%) participants were seropositive. Of the seronegative participants, 6/198 (3.0%), 6/183 (3.3%), and 14/180 (7.8%) had seroconverted at T3, T6, and T9, respectively. The overall seroreversion rate was 6.98% at T9. At T0, nursing staff (odds ratio [OR], 2.37; 95% confidence interval [CI], 1.08, 5.19) and being within six feet of a non-household member outside of work (OR, 2.91; 95% CI, 1.02, 8.33) had significantly higher odds of seropositivity. Vaccination (OR, 0.05; 95% CI, 0.02, 0.12) and face mask use (OR, 0.36; 95% CI, 0.17, 0.78) were protective.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The seroconversion and seroreversion rates were low among participants. Public health and infection prevention measures implemented early in the COVID-19 pandemic - vaccination, face mask use, and social distancing - were associated with significantly lower odds of SARS-CoV-2 seropositivity among participants.</AbstractText><CopyrightInformation>© The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Brianna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuette</LastName><ForeName>Allison</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0968-0340</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of Iowa College of Public Health, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-1054-6475</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasowski</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0003-0856-8402</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Aaron M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-4134-9300</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diekema</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavanaugh</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0514-7664</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of Iowa College of Public Health, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herwaldt</LastName><ForeName>Loreen</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9530-6859</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Steward Healthc Epidemiol</MedlineTA><NlmUniqueID>9918266096106676</NlmUniqueID><ISSNLinking>2732-494X</ISSNLinking></MedlineJournalInfo><CoiStatement>BW, DK, AS, MAW, MDK, AMS, and JC report no conflicts of interest relevant to this article. DJD reports research funding from BioMerieux, Inc. and Affinity Biosensors. LH reports having receiving povidone iodine product for unrelated clinical trials from 3M and from PDI.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465214</ArticleId><ArticleId IdType="pmc">PMC11505257</ArticleId><ArticleId IdType="doi">10.1017/ash.2024.420</ArticleId><ArticleId IdType="pii">S2732494X24004200</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beh CC, Zulkufli NS, Loh LM, et al. SARS-CoV-2 seroprevalence and antibody trends in vaccinated, multi-ethnic healthcare employees. Trop Biomed 2021;38:552–560. doi: 10.47665/tb.38.4.098</Citation><ArticleIdList><ArticleId IdType="doi">10.47665/tb.38.4.098</ArticleId><ArticleId IdType="pubmed">35001921</ArticleId></ArticleIdList></Reference><Reference><Citation>Brousseau N, Morin L, Ouakki M, et al. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study. CMAJ 2021;193:E1868–E1877. doi: 10.1503/cmaj.202783</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.202783</ArticleId><ArticleId IdType="pmc">PMC8677578</ArticleId><ArticleId IdType="pubmed">34903591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan A, Tatem K, Diuguid-Gerber J, et al. Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York. BMJ Open 2021;11:e053158. doi: 10.1136/bmjopen-2021-053158</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-053158</ArticleId><ArticleId IdType="pmc">PMC8572359</ArticleId><ArticleId IdType="pubmed">34732494</ArticleId></ArticleIdList></Reference><Reference><Citation>Plebani M, Padoan A, Fedeli U, et al. SARS-CoV-2 serosurvey in health care workers of the Veneto Region. Clin Chem Lab Med 2020;58:2107–2111. doi: 10.1515/cclm-2020-1236</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-1236</ArticleId><ArticleId IdType="pubmed">32845861</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscola J, Sembajwe G, Jarrett M, et al. Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York city area. JAMA 2020;324:893–895. doi: 10.1001/jama.2020.14765</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.14765</ArticleId><ArticleId IdType="pmc">PMC7411936</ArticleId><ArticleId IdType="pubmed">32780804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeremias A, Nguyen J, Levine J, et al. Prevalence of SARS-CoV-2 infection among health care workers in a tertiary community hospital. JAMA Intern Med 2020;180:1707–1709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7420823</ArticleId><ArticleId IdType="pubmed">32780100</ArticleId></ArticleIdList></Reference><Reference><Citation>Self WH, Tenforde MW, Stubblefield WB, et al. Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 academic medical centers, April-June 2020. MMWR Morb Mortal Wkly Rep 2020;69:1221–1226. doi: 10.15585/mmwr.mm6935e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6935e2</ArticleId><ArticleId IdType="pmc">PMC7470460</ArticleId><ArticleId IdType="pubmed">32881855</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour M, Leven E, Muellers K, Stone K, Mendu DR, Wajnberg A. Prevalence of SARS-CoV-2 antibodies among healthcare workers at a tertiary academic hospital in New York city. J Gen Intern Med 2020;35:2485–2486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269421</ArticleId><ArticleId IdType="pubmed">32495088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sydney ER, Kishore P, Laniado I, Rucker LM, Bajaj K, Zinaman MJ. Antibody evidence of SARS-CoV-2 infection in healthcare workers in the Bronx. Infect Control Hosp Epidemiol 2020;41:1348–1349. doi: 10.1017/ice.2020.437</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.437</ArticleId><ArticleId IdType="pmc">PMC7503039</ArticleId><ArticleId IdType="pubmed">32843121</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubblefield WB, Talbot HK, Feldstein LR, et al. Seroprevalence of SARS-CoV-2 among frontline healthcare personnel during the first month of caring for patients with COVID-19—Nashville, Tennessee. Clin Infect Dis 2021;72:1645–1648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454447</ArticleId><ArticleId IdType="pubmed">32628750</ArticleId></ArticleIdList></Reference><Reference><Citation>Amendola A, Tanzi E, Folgori L, et al. Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave. Infect Control Hosp Epidemiol 2020;41:1468–1469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438626</ArticleId><ArticleId IdType="pubmed">32758311</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant JJ, Wilmore SM, McCann NS, et al. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust. Infect Control Hosp Epidemiol 2021;42:212–214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438618</ArticleId><ArticleId IdType="pubmed">32746953</ArticleId></ArticleIdList></Reference><Reference><Citation>Iversen K, Bundgaard H, Hasselbalch RB, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis 2020;20:1401–1408. doi: 10.1016/S1473-3099(20)30589-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30589-2</ArticleId><ArticleId IdType="pmc">PMC7398038</ArticleId><ArticleId IdType="pubmed">32758438</ArticleId></ArticleIdList></Reference><Reference><Citation>Paderno A, Fior M, Berretti G, et al. SARS-CoV-2 infection in health care workers: cross-sectional analysis of an otolaryngology unit. Otolaryngol Head Neck Surg 2020;163:671–672. doi: 10.1177/0194599820932162</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820932162</ArticleId><ArticleId IdType="pubmed">32482123</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudberg A-S, Havervall S, Månberg A, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun 2020;11:5064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544689</ArticleId><ArticleId IdType="pubmed">33033249</ArticleId></ArticleIdList></Reference><Reference><Citation>Steensels D, Oris E, Coninx L, et al. Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium. JAMA 2020;324:195–197. doi: 10.1001/jama.2020.11160</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.11160</ArticleId><ArticleId IdType="pmc">PMC7296458</ArticleId><ArticleId IdType="pubmed">32539107</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob JT, Baker JM, Fridkin SK, et al. Risk factors associated with SARS-CoV-2 seropositivity among US health care personnel. JAMA Netw Open 2021;4:e211283. doi: 10.1001/jamanetworkopen.2021.1283</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.1283</ArticleId><ArticleId IdType="pmc">PMC7948059</ArticleId><ArticleId IdType="pubmed">33688967</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins JT, Hirschhorn LR, Gray EL, et al. Serologic status and SARS-CoV-2 infection over 6 months of follow up in healthcare workers in Chicago: a cohort study. Infect Control Hosp Epidemiol 2022;43:1207–1215. doi: 10.1017/ice.2021.367</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2021.367</ArticleId><ArticleId IdType="pmc">PMC8438416</ArticleId><ArticleId IdType="pubmed">34369331</ArticleId></ArticleIdList></Reference><Reference><Citation>Papasavas P, Olugbile S, Wu U, et al. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut. J Hosp Infect 2021;114:117–125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8076763</ArticleId><ArticleId IdType="pubmed">33930487</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings J, Ching BCF, Gkofa V, Greene T, Bloomfield M. Experiences of frontline healthcare workers and their views about support during COVID-19 and previous pandemics: a systematic review and qualitative meta-synthesis. BMC Health Serv Res 2021;21:1–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8419805</ArticleId><ArticleId IdType="pubmed">34488733</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Zhou M, Tang F, et al. Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in Henan, China. J Hosp Infect 2020;105:183–187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194961</ArticleId><ArticleId IdType="pubmed">32278701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottolenghi J, McLaren RA, Jr., Bahamon C, Dalloul M, McCalla S, Minkoff H. Health care workers’ attitudes toward patients with COVID-19. Open Forum Infect Dis 2021;8:ofab375. doi: 10.1093/ofid/ofab375</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab375</ArticleId><ArticleId IdType="pmc">PMC8339607</ArticleId><ArticleId IdType="pubmed">34377732</ArticleId></ArticleIdList></Reference><Reference><Citation>Jespersen S, Mikkelsen S, Greve T, et al. Severe acute respiratory syndrome coronavirus 2 seroprevalence survey among 17 971 healthcare and administrative personnel at hospitals, prehospital services, and specialist practitioners in the Central Denmark Region. Clin Infect Dis 2021;73:e2853–e2860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797753</ArticleId><ArticleId IdType="pubmed">33011792</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore RC, Lee AY, Hancock JT, Halley MC, Linos E. Age-related differences in experiences with social distancing at the onset of the COVID-19 pandemic: a computational and content analytic investigation of natural language from a social media survey. JMIR Hum Factors 2021;8:e26043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8191726</ArticleId><ArticleId IdType="pubmed">33914689</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Cheng Y, Sui M. The moderating effects of perceived severity on the generational gap in preventive behaviors during the COVID-19 pandemic in the US. Int J Environ Res Public Health 2021;18:2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7922035</ArticleId><ArticleId IdType="pubmed">33669713</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudberg A-S, Havervall S, Manberg A, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers. Nat Commun 2020;11:5064</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544689</ArticleId><ArticleId IdType="pubmed">33033249</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard-Anderson JR, Adams C, Dube WC, et al. Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study. Infect Control Hosp Epidemiol 2022;43:1664–1671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8886081</ArticleId><ArticleId IdType="pubmed">35156597</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoberer D, Osmancevic S, Reiter L, Thonhofer N, Hoedl M. Rapid review and meta-analysis of the effectiveness of personal protective equipment for healthcare workers during the COVID-19 pandemic. Public Health Pract (Oxf) 2022;4:100280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9190185</ArticleId><ArticleId IdType="pubmed">35722539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran L, Chen X, Wang Y, Wu W, Zhang L, Tan X. Risk factors of healthcare workers with coronavirus disease 2019: a retrospective cohort study in a designated hospital of Wuhan in China. Clin Infect Dis. 2020;71:2218–2221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184482</ArticleId><ArticleId IdType="pubmed">32179890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JT, Fung KS, Wong TW, et al. SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis 2004;10:280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3322933</ArticleId><ArticleId IdType="pubmed">15030698</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med 2020;180:1156–1163. doi: 10.1001/jamainternmed.2020.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.2020</ArticleId><ArticleId IdType="pmc">PMC7195694</ArticleId><ArticleId IdType="pubmed">32356867</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun KM, Moreno GK, Buys A, et al. Viral sequencing to investigate sources of SARS-CoV-2 infection in US healthcare personnel. Clin Infect Dis 2021;73:e1329–e1336. doi: 10.1093/cid/ciab281</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab281</ArticleId><ArticleId IdType="pmc">PMC8083259</ArticleId><ArticleId IdType="pubmed">33857303</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S, Bhattacharya M, Nag S, Dhama K, Chakraborty C. A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies. Viruses 2023;15:167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9866114</ArticleId><ArticleId IdType="pubmed">36680207</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker H, Li H, Zhang Y, et al. Association Between Behavior and Risk of COVID-19 in A Cohort of Healthcare Personnel. Oxford University Press, US. 2023:ofad500.</Citation></Reference><Reference><Citation>Fisher BT, Sharova A, Boge CL, et al. Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children’s hospital during coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2022;43:1647–1655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8668398</ArticleId><ArticleId IdType="pubmed">34852866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkens JJ, Buis DTP, Peters EJG, et al. Serologic surveillance and phylogenetic analysis of SARS-CoV-2 infection among hospital health care workers. JAMA Netw Open 2021;4:e2118554. doi: 10.1001/jamanetworkopen.2021.18554</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.18554</ArticleId><ArticleId IdType="pmc">PMC9437910</ArticleId><ArticleId IdType="pubmed">34319354</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen N, Brady M, Carrion Martin AI, et al. SARS-CoV-2 antibody testing in health care workers: a comparison of the clinical performance of three commercially available antibody assays. Microbiol Spectr 2021;9:e0039121. doi: 10.1128/Spectrum.00391-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00391-21</ArticleId><ArticleId IdType="pmc">PMC8557912</ArticleId><ArticleId IdType="pubmed">34585976</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R, Chen K, Winner D, Friedhoff S, Wardle C. A systematic review of COVID-19 misinformation interventions: lessons learned: study examines COVID-19 misinformation interventions and lessons learned. Health Affairs 2023;42:1738–1746.</Citation><ArticleIdList><ArticleId IdType="pubmed">37967291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira Caceres MM, Sosa JP, Lawrence JA, et al. The impact of misinformation on the COVID-19 pandemic. AIMS Public Health 2022;9:262–277. doi: 10.3934/publichealth.2022018</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/publichealth.2022018</ArticleId><ArticleId IdType="pmc">PMC9114791</ArticleId><ArticleId IdType="pubmed">35634019</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>